Philip Morris International CEO on Q2 Earnings and Transition to Smoke-Free Products

Q2 Earnings and Performance

• 📈 Philip Morris International (PMI) CEO Jacek Olczak expressed satisfaction with the company's performance in the second quarter and first half of the year.
• ⚡ Despite past capacity constraints leading to out-of-stock situations, PMI has accelerated capacity expansion in the US, enabling full market supply.
• 🚀 The company is experiencing strong sequential development for its Zen product, with growth rates approaching 40%.

Transition to Smoke-Free Products

• 🎯 PMI's goal is to transition consumers away from traditional cigarettes towards smoke-free alternatives by the end of the decade.
• ⚠️ A significant constraint to this progress is the regulatory front, with a hope that the FDA will accelerate its processing of Premarket Tobacco Product Applications (PMTAs).
• 💬 Olczak noted a more frequent, open, and transparent dialogue with the FDA compared to the past, expressing optimism for the processing of outstanding PMTAs.

Future of Smoke-Free Products

• 💡 The approval of products like IQOS (referred to as 'dicosoma' and 'Zen') is crucial for PMI's investment in US manufacturing and further expansion.
• 🧩 PMI is selectively entering markets for its VEEV product, focusing on legitimate markets with clear regulatory processes to properly serve adult consumers.
• ✅ The strategy for VEEV has resulted in strong volume growth and is beginning to show accretion to the company's bottom line.